New study ranks performance of currently available COVID-19 antibody tests

July 15, 2020

A new peer-reviewed study by researchers at NSF International and Novateur Ventures finds significant variability in the accuracy of currently available COVID-19 antibody tests. The study, "Diagnostics, an international peer-reviewed open-access journal published monthly by the Multidisciplinary Publishing Institute (MDPI).

In the absence of vaccines and effective therapeutics for SARS-CoV-2 and the associated COVID-19 disease, reliable antibody testing can be a key element of public health policy to control further spread of the disease and gradually ease quarantine measures.

The study was coauthored by Robyn Meurant, Executive Director of Health Sciences for NSF International, Abdi Ghaffari, Advisor in Scientific affairs at Novateur Ventures and an Adjunct Associate Professor at the Department of Pathology and Molecular Medicine at Queen's University, and Ali Ardakani, Founder & Managing Director at Novateur Ventures.

The urgent need for the development of antibody diagnostic tests in response to the COVID-19 pandemic has compelled regulatory bodies to implement emergency use authorization programs to expedite the commercialization process of these tests. "Granting FDA Emergency Use Authorization to several companies to accelerate the manufacturing of diagnostic tests was a good move," said Ghaffari. "But it must be accompanied by informed and clear guidelines on preferred and minimally acceptable profiles of the COVID-19 antibody tests designed for a specific indication."

Published independent performance data of five CLIA (chemiluminescence immunoassay), 15 ELISA (enzyme-linked immunosorbent assay) and 42 RDT (rapid diagnostic test) antibody tests that are currently on the market were reviewed for this study to understand their limits and potential.

"No single assay can be used for all diagnostic use cases in the COVID-19 response for a country," said Meurant. "What works well in one setting may be inappropriate or not accessible for another. As such, access to information on test performance, that is generated independently, greatly assists countries in informed decision-making."

The findings show significant variability in the accuracy of marketed tests and highlight several lab-based and point-of-care rapid diagnostic tests with high performance levels in detecting SARS-CoV-2 specific antibodies. The findings of this review highlight the need for ongoing independent evaluations of commercialized COVID-19 diagnostic tests.

"Antibody testing is important to understanding the extent of exposure for COVID-19 so it can be effectively monitored and treated," said Ardakani. "It is important for regional and national governments to continue their coordinated efforts to independently validate antibody test performance and also partner with industry to scale up manufacturing and production capacity."

Thirteen top-performing COVID-19 antibody tests were identified in this study based on independent evaluations of their sensitivity (ability to correctly identify those with the disease) and specificity (ability to correctly identify those without the disease) data (>95% accuracy).

In any infectious disease outbreak, accurate and accessible diagnostic testing must be one of the pillars of control measure policies to understand and minimize the spread of disease. The epidemiological studies of the outbreak in China estimated the proportion of undetected COVID-19 cases to be as high as 86% . As asymptomatic or mild cases could play a significant role in the transmission and spread of the SARS-CoV-2 virus, symptoms alone are not reliable diagnostic markers.

There are two major types of diagnostic technologies available to address this: molecular and antibody (sometimes called serological) tests. Currently, much of the focus is on the SARS-CoV-2 molecular test, which can detect, with high accuracy, the viral-specific RNA molecules circulating in the host body. However, the molecular test is not useful in distinguishing between highly infective viruses versus ones that have been neutralized by the host, and it cannot assess immunity status against SARS-CoV-2. Antibody tests can complement molecular-based tests in providing a more accurate estimate of SARS-CoV-2 incidence and potentially detect individuals with immunity against the disease as these tests detect markers of the immune response.
About NSF International

NSF International (

About Novateur Ventures

Novateur is an established global life sciences advisory with extensive experience related to business development and product development of therapeutics, medical devices and digital health products. For more information, visit:

NSF International

Related Accuracy Articles from Brightsurf:

Accuracy of rapid COVID test may be lower than previously suggested
The accuracy of a rapid finger-prick antibody test for SARS-CoV-2, the virus responsible for covid-19 infection, may be considerably lower than previously suggested, finds a study published by The BMJ.

Patients' breathing test comes up short on accuracy, study finds
A routine test used to monitor patients' breathing may be unreliable and putting them at risk, a study suggests.

New perception metric balances reaction time, accuracy
Researchers at Carnegie Mellon University have developed a new metric for evaluating how well self-driving cars respond to changing road conditions and traffic, making it possible for the first time to compare perception systems for both accuracy and reaction time.

Improving the accuracy of typhoon forecasts with radar data assimilation
After the adjustment and improvement of the typhoon structure, the accuracies of the 12-h track and accumulated precipitation forecasts were significantly improved.

Owner behavior affects effort and accuracy in dogs' communications
Researchers from the Max Planck Institute for the Science of Human History and Friedrich Schiller University in Jena have found that dogs adapt their communicative strategies to their environment and that owner behavior influences communicative effort and success.

Cardiorespiratory fitness assessment improves accuracy of health predictions
According to a new study in Mayo Clinic Proceedings, published by Elsevier, taking cardiorespiratory fitness (CRF) into account along with traditional risk factors such as age, sex, blood pressure, cholesterol, and smoking, improves the accuracy of mortality risk assessment.

New framework brings accuracy, efficiency to identifying stop words
Professor Luis Amaral and postdoctoral fellow Martin Gerlach's algorithmic approach automatically recognizes uninformative words in large collections of text, which could help researchers dramatically reduce computational requirements during data analyses.

Pinpointing biomolecules with nanometer accuracy
Scientists at Tokyo Institute of Technology (Tokyo Tech) demonstrate a new approach in fluorescence microscopy that can be used to locate individual biomolecules in 3D space with nanometer-scale precision.

New algorithm can distinguish cyberbullies from normal Twitter users with 90% accuracy
A team of researchers, including faculty at Binghamton University, have developed machine learning algorithms which can successfully identify bullies and aggressors on Twitter with 90 percent accuracy.

AI improves efficiency and accuracy of digital breast tomosynthesis
Artificial intelligence (AI) helps improve the efficiency and accuracy of an advanced imaging technology used to screen for breast cancer, according to a new study.

Read More: Accuracy News and Accuracy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to